UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity

PloS one, 2013-01, Vol.8 (1), p.e53623-e53623

2013

Volltextzugriff (PDF)

A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients — A twelve month follow-up

Journal of neuroimmunology, 2015-08, Vol.285, p.68-70

2015

Volltextzugriff (PDF)

Temelimab, an IgG4 Anti-Human Endogenous Retrovirus Monoclonal Antibody: An Early Development Safety Review

Drug safety, 2020-12, Vol.43 (12), p.1287-1296

2020

Volltextzugriff (PDF)

Is massage a legitimate part of nursing care? A qualitative study

PloS one, 2023-02, Vol.18 (2), p.e0281078-e0281078

2023

Volltextzugriff (PDF)

Meta‐analysis combining parallel and cross‐over trials with random effects

Research synthesis methods, 2017-09, Vol.8 (3), p.263-274

Curtin, François

2017

Volltextzugriff (PDF)

Meta‐analysis combining parallel and crossover trials using generalised estimating equation method

Research synthesis methods, 2017-09, Vol.8 (3), p.312-320

Curtin, François

2017

Volltextzugriff (PDF)

Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes

Statistics in medicine, 2002-08, Vol.21 (15), p.2131-2144

2002

Volltextzugriff (PDF)

Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva Cocktail

Clinical pharmacology and therapeutics, 2021-06, Vol.109 (6), p.1668-1676

2021

Volltextzugriff (PDF)

Impact of SARS‐CoV‐2 Infection (COVID‐19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail

Clinical pharmacology and therapeutics, 2021-11, Vol.110 (5), p.1358-1367

2021

Volltextzugriff (PDF)

Corrections to effect size variances for continuous outcomes of crossover clinical trials

Statistics in medicine, 2018-01, Vol.37 (2), p.320-323

2018

Volltextzugriff (PDF)

Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

EBioMedicine, 2016-04, Vol.6, p.190-198

2016

Volltextzugriff (PDF)

A High-dose Pharmacokinetic Study of a New IgG4 Monoclonal Antibody Temelimab/GNbAC1 Antagonist of an Endogenous Retroviral Protein pHERV-W Env

Clinical therapeutics, 2019-09, Vol.41 (9), p.1737-1746

2019

Volltextzugriff (PDF)

Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients

Frontiers in aging neuroscience, 2022-09, Vol.14, p.957665

2022

Volltextzugriff (PDF)

Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes

Statistics in medicine, 2002-08, Vol.21 (15), p.2145-2159

2002

Volltextzugriff (PDF)

Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis

Journal of affective disorders, 2004-03, Vol.78 (3), p.201-208

2004

Volltextzugriff (PDF)

The role of adaptive trial designs in drug development

Expert review of clinical pharmacology, 2017-07, Vol.10 (7), p.727-736

2017

Volltextzugriff (PDF)

Antiviral Use in Mild-to-Moderate SARS-CoV-2 Infections during the Omicron Wave in Geriatric Patients

Viruses, 2024-06, Vol.16 (6), p.864

2024

Volltextzugriff (PDF)

Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein

mAbs, 2015-01, Vol.7 (1), p.265-275

2015

Volltextzugriff (PDF)

Meta-analyses involving cross-over trials: methodological issues

International journal of epidemiology, 2011-12, Vol.40 (6), p.1732-1734

2011

Volltextzugriff (PDF)

Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol

Pharmaceuticals (Basel, Switzerland), 2023-08, Vol.16 (9), p.1227

2023

Volltextzugriff (PDF)

GNbAC1, a Humanized Monoclonal Antibody Against the Envelope Protein of Multiple Sclerosis—Associated Endogenous Retrovirus: A First-in-Humans Randomized Clinical Study

Clinical therapeutics, 2012-12, Vol.34 (12), p.2268-2278

2012

Volltextzugriff (PDF)

Genetic Susceptibility Toward Nausea and Vomiting in Surgical Patients

Frontiers in genetics, 2022-01, Vol.12, p.816908-816908

2022

Volltextzugriff (PDF)

Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocol

Frontiers in pain research (Lausanne, Switzerland), 2023-05, Vol.4, p.1108832-1108832

2023

Volltextzugriff (PDF)

A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients

Multiple sclerosis, 2015-06, Vol.21 (7), p.885-893

2015

Volltextzugriff (PDF)

Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: A Phase 1 study

mAbs, 2016-07, Vol.8 (5), p.854-860

2016

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(71)
Humans
(55)
Biological And Medical Sciences
(26)
Male
(21)
Female
(20)
Medical Sciences
(19)
Neurosciences & Neurology
(19)
Adult
(18)
Middle Aged
(17)
Multiple Sclerosis
(17)
Neurosciences
(15)
Public, Environmental & Occupational Health
(14)
Pharmacology & Pharmacy
(13)
Clinical Neurology
(12)
Monoclonal Antibody
(11)
General & Internal Medicine
(9)
Medicine, General & Internal
(9)
Cross-Over Studies
(8)
Multiple Sclerosis - Drug Therapy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity

A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients — A twelve month follow-up

Temelimab, an IgG4 Anti-Human Endogenous Retrovirus Monoclonal Antibody: An Early Development Safety Review

Is massage a legitimate part of nursing care? A qualitative study

Meta‐analysis combining parallel and cross‐over trials with random effects

Meta‐analysis combining parallel and crossover trials using generalised estimating equation method

Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes

Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva Cocktail

Impact of SARS‐CoV‐2 Infection (COVID‐19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail

Corrections to effect size variances for continuous outcomes of crossover clinical trials

Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

A High-dose Pharmacokinetic Study of a New IgG4 Monoclonal Antibody Temelimab/GNbAC1 Antagonist of an Endogenous Retroviral Protein pHERV-W Env

Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients

Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes

Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis

The role of adaptive trial designs in drug development

Antiviral Use in Mild-to-Moderate SARS-CoV-2 Infections during the Omicron Wave in Geriatric Patients

Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein

Meta-analyses involving cross-over trials: methodological issues

Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol

GNbAC1, a Humanized Monoclonal Antibody Against the Envelope Protein of Multiple Sclerosis—Associated Endogenous Retrovirus: A First-in-Humans Randomized Clinical Study

Genetic Susceptibility Toward Nausea and Vomiting in Surgical Patients

Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocol

A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients

Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: A Phase 1 study

Suchergebnisse filtern